Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Stocks

Goldman Sachs Sticks to Buy Rating for Johnson & Johnson

Guavy AI Editorial Team
Instruments
JNJ
Share

Goldman Sachs analyst Asad Haider has reaffirmed his 'Buy' rating on Johnson & Johnson (JNJ.US) and maintained a target price of $282. This decision is based on Haider's impressive track record, with a 92.7% success rate over the past year.

According to TipRanks data, Haider has achieved an average return of 30.4% over the same period. The analyst's performance is evaluated using a ranking system that assigns up to 5 stars, and Haider currently holds 5-star status.

More on Stocks

Stocks just now

Nvidia Earnings Hinge on AI Spending Guidance

Stocks 1m ago

Nvidia Eyes Strong Q2 Earnings Amid Investor Positioning

Stocks 1m ago

Nvidia Poised for 'Monster Beat' as Earnings Loom

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy